Developing Next-Generation TCR-T Therapies by CD8 Co-Expression

Time: 11:45 am
day: Day 2 - Track C - Morning


  • Outlining next-gen approaches for TCR-engineered T-cell therapies for solid tumors
  • Enhancement of anti-tumor immune responses through effective engagement of CD4 T cells
  • Exploring the differential functional profiles of TCR-T cells co-expressing different types of CD8 co-receptors